Prevalent Sodium-Glucose Co-Transporter 2 Inhibitor Use, Baseline Laboratory Profile, and Clinical Outcomes in a Real-World Heart Failure Cohort-Uncorrected Proof
Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology · 2026 · 54 (54) · 6-6
DOI: 10.5543/tkda.2026.27385 ↗Kurz gefasst
Fachartikel in der Zeitschrift Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 2026. Verfasst von Sevil Tuğrul Yavuz und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- Department of Cardiology, Başakşehir Çam and Sakura City Hospital, İstanbul, Türkiye.
- Department of Cardiology, Nişantaşı University, İstanbul, Türkiye.
- Department of Cardiology, Istanbul Medipol University, İstanbul, Türkiye.
Zitieren
APA
Tuğrul Yavuz, S., İşleyen, H. B., İnan, D., Özsaray, F. Z., Şahin, K. K., Özanalp, C., Hamkan, E., Genç Albayrak, D., Hancıoğlu, E., & Kılıçgedik, A. (2026). Prevalent Sodium-Glucose Co-Transporter 2 Inhibitor Use, Baseline Laboratory Profile, and Clinical Outcomes in a Real-World Heart Failure Cohort-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology, 54(54), 6-6. https://doi.org/10.5543/tkda.2026.27385
Vancouver
Tuğrul Yavuz S, İşleyen HB, İnan D, Özsaray FZ, Şahin KK, Özanalp C, et al. Prevalent Sodium-Glucose Co-Transporter 2 Inhibitor Use, Baseline Laboratory Profile, and Clinical Outcomes in a Real-World Heart Failure Cohort-Uncorrected Proof. Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology. 2026;54(54):6-6. doi:10.5543/tkda.2026.27385
BibTeX
@article{TurulYavuz2026,
author = {Tuğrul Yavuz, Sevil and İşleyen, Hasan Burak and İnan, Duygu and Özsaray, Fatmatüz Zehra and Şahin, Kadir Kasım and Özanalp, Cemal and Hamkan, Emel and Genç Albayrak, Duygu and Hancıoğlu, Emir and Kılıçgedik, Alev},
title = {Prevalent Sodium-Glucose Co-Transporter 2 Inhibitor Use, Baseline Laboratory Profile, and Clinical Outcomes in a Real-World Heart Failure Cohort-Uncorrected Proof},
journal = {Turk Kardiyoloji Dernegi Arsivi-Archives of the Turkish Society of Cardiology},
year = {2026},
volume = {54},
number = {54},
pages = {6--6},
doi = {10.5543/tkda.2026.27385}
}
EUVIMED